Hubei Jumpcan (China) Investor Sentiment

600566 Stock   29.84  1.33  4.67%   
About 55% of Hubei Jumpcan's investors are presently thinking to get in. The analysis of overall sentiment of trading Hubei Jumpcan Pharmaceutical stock suggests that some investors are interested at this time. The current market sentiment, together with Hubei Jumpcan's historical and current headlines, can help investors time the market. In addition, many technical investors use Hubei Jumpcan Pharma stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Hubei Jumpcan Pharmaceutical sheds 5.6 percent this week, as yearly returns fall more in line with e...
Google News at Macroaxis
over two months ago at news.google.com         
Hubei Jumpcan Pharmaceutical Co., Ltd.s market cap surged CN2.3b last week, private companies who ha...
Google News at Macroaxis
over two months ago at news.google.com         
Why Investors Shouldnt Be Surprised By Hubei Jumpcan Pharmaceutical Co., Ltd.s 26 percent Share Pric...
Google News at Macroaxis
over two months ago at news.google.com         
An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. Suggests Its 45 percent Underval...
Google News at Macroaxis
over three months ago at news.google.com         
Hubei Jumpcan Pharmaceutical Second Quarter 2024 Earnings EPS CN0.53 - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Rabeprazole Sodium Enteric-Coated Tablets Market Size, Share - openPR
Google News at Macroaxis
over three months ago at news.google.com         
Lidocaine Hydrochloride Injection Market Size, Share - openPR
Google News at Macroaxis
over three months ago at news.google.com         
Is Now The Time To Put Hubei Jumpcan Pharmaceutical On Your Watchlist - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Why You Might Be Interested In Hubei Jumpcan Pharmaceutical Co., Ltd. For Its Upcoming Dividend - Si...
Google News at Macroaxis
over six months ago at news.google.com         
Hubei Jumpcan Pharmaceutical Co., Ltd.s Prospects Need A Boost To Lift Shares - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Investing in Hubei Jumpcan Pharmaceutical three years ago would have delivered you a 137 percent gai...
Google News at Macroaxis
over six months ago at news.google.com         
Hubei Jumpcan Pharmaceutical First Quarter 2024 Earnings EPS CN0.92 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Hubei Jumpcan Pharmaceutical Full Year 2023 Earnings EPS Beats Expectations, Revenues Lag - Simply W...
Google News at Macroaxis
over six months ago at news.google.com         
Individual investors own 27 percent of Hubei Jumpcan Pharmaceutical Co., Ltd. shares but private com...
Google News at Macroaxis
over six months ago at news.google.com         
HUBEI JUMPCAN PHARMACEUTICAL Revenue Breakdown SSE600566 TradingView - TradingView
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Hubei Jumpcan that are available to investors today. That information is available publicly through Hubei media outlets and privately through word of mouth or via Hubei internal channels. However, regardless of the origin, that massive amount of Hubei data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hubei Jumpcan news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hubei Jumpcan relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hubei Jumpcan's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hubei Jumpcan alpha.

Hubei Jumpcan Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. Suggests Its 45 percent Undervalued - Simply Wall St
09/09/2024
2
Hubei Jumpcan Pharmaceutical sheds 5.6 percent this week, as yearly returns fall more in line with earnings growth - Simply Wall St
11/22/2024

Complementary Tools for Hubei Stock analysis

When running Hubei Jumpcan's price analysis, check to measure Hubei Jumpcan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hubei Jumpcan is operating at the current time. Most of Hubei Jumpcan's value examination focuses on studying past and present price action to predict the probability of Hubei Jumpcan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hubei Jumpcan's price. Additionally, you may evaluate how the addition of Hubei Jumpcan to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing